Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice - natural resistance and immune responsiveness

Anti-Cancer Drugs

Volumn 7, Issue 7, 1996, Pages 785-791

  Serša, Gregor ^a   Kotnik, Vladimir ^b   Čemažar, Maja ^a   Miklavčič, Damijan ^b   Kotnik, Antonija ^c  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

Author keywords

Bleomycin; Electrochemotherapy; Fibrosarcoma; Immune responsiveness

Indexed keywords

BLEOMYCIN; CONCANAVALIN A; MITOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLAST TRANSFORMATION; CANCER GRAFT; CONTROLLED STUDY; ELECTROCHEMOTHERAPY; FEMALE; FIBROSARCOMA; HOST RESISTANCE; IMMUNE RESPONSE; INTRACELLULAR KILLING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; SPLEEN CELL; T LYMPHOCYTE; VENOUS BLOOD;

EID: 0029859843     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199609000-00011     Document Type: Article

References (26)

1. Mir LM, Orlowski S, Belehradek J Jr, et al. Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectrocb Bioener 1995; 38: 203-7.
2. Orlowski S, Mir LM. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1993; 1154: 51-63.
3. Potter H. Electroporation in biology: methods, applications, and instrumentation. Anal Biochem 1988; 174: 361-73.
4. Rols MP, Teissie J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys J 1990; 58: 1089-98.
5. Tsong TY. Electroporation of cell membranes. Biophys J 1991; 60: 297-306.
6. Weaver JC. Molecular basis for cell membrane electroporation. Ann NY Acad Sci 1994; 720: 141-52.
7. Orlowski S, Belehradek J Jr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase in cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727-33.
8. Poddevin B, Orlowski S, Belehradek J Jr, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991; 42: S67-S75.
9. Melvik JE, Pettersen EO, Gordon PB, Selgen PO. Increase in cis-dichlorodiammineplatinum(II) cytotoxicity upon revesible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur J Cancer Clin Oncol 1986; 22: 1523-30.
10. Serša G, Čemažar M, Miklavčič D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995; 55: 3450-5.
11. Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991; 27: 73-6.
12. Čemažar M, Miklavčič D, Vodovnik L, et al. Improved effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice. Radiol Oncol 1995, 29: 121-7.
13. Heller R, Jaroszeski M, Leo-Messina J, et al. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectroch Bioener 1995, 36: 83-7.
14. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68-72.
15. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992; 3: 331-4.
16. Okino M, Mohri H. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res 1987; 78: 1319-21.
17. Okino M, Esato K. The effects of a single high voltage-electrical stimulation with an anticancer drug on in vivo growing malignant tumors. Jpn J Surg 1990; 20: 197-204.
18. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electrical conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992; 83: 1095-101.
19. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PCh, Mir LM. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 1993; 194: 938-43.
20. Serša G, Čemažar M, Miklavčič D, Mir LM. Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectroch Bioener 1994; 35: 23-7.
21. Serša G, Čemažar M, Šemrov D, Miklavčič D. Changing electrode orientation improves the efficacy of electrochemotherapy on solid tumors in mice. Bioelectroch Bioener 1996; 39: 61-6.
22. Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964-71.
23. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek Jr J, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993; 72: 3694-700.
24. Rudolf Z, Štabuc B, Čemažar M, Miklavčič D, Vodovnik L, Serša G. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol Oncol 1995; 29: 229-35.
25. Domenge C, Orlowski S, Luboinski B, et al. Antitumor electrochemotherapy. New advances in the clinical protocol. Cancer 1996; 5: 956-63.
26. Mir LM, Roth C, Orlowski S, et al. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother 1995; 17: 30-8.